Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 4
Submit an article Journal homepage
542
Views
54
CrossRef citations to date
0
Altmetric
Review

Autism spectrum disorders: a review of measures for clinical, health services and cost–effectiveness applications

Nalin Payakachat Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. [email protected]
,
J Mick Tilford Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, USA
,
Erica Kovacs Department of Psychiatry, Columbia University, New York, NY, USA
&
Karen Kuhlthau Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Center for Adolescent Health Policy, Massachusetts General Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Center for Adolescent Health Policy, Massachusetts General Hospital, Boston, MA, USA
Pages 485-503 | Published online: 09 Jan 2014

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV TR. Amer Psychiatric Publishing, Arlington, VA, USA (2000).
  • Strock M. Autism Spectrum Disorders (Pervasive Developmental Disorders). National Institutes of Mental Health, NIH, US Department of Health and Human Services; Report No. NIH-04-5511. NIH MD, USA (2004).
  • Lord C, Bishop SL. Autism spectrum disorders: diagnosis, prevalence, and services for children and families. Soc. Pol. Rep. 24(2), 1–25 (2010).
  • Saulnier C, Quirmbach L, Klin A. Clinical evaluation of children with autism spectrum disorders. In: Textbook of Autism Spectrum Disorders. Hollander E, Kolevzon A, Coyle JT (Eds). American Psychiatric Publishing, Inc., VA, USA, 25–37 (2011).
  • Lord C, Petkova E, Hus V et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch. Gen. Psychiatry 69(3), 306–313 (2012).
  • Toth K, King BH. Asperger’s syndrome: diagnosis and treatment. Am. J. Psychiatry 165(8), 958–963 (2008).
  • Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J. Child Psychol. Psychiatry. 45(2), 212–229 (2004).
  • Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism 13(3), 317–336 (2009).
  • Wang L, Leslie DL. Health care expenditures for children with autism spectrum disorders in Medicaid. J. Am. Acad. Child Adolesc. Psychiatry 49(11), 1165–1171 (2010).
  • Volkmar FR, Paul R, Klin A, Cohen D. Handbook of Autism and Pervasive Developmental Disorders (3rd Edition). John Wiley & Sons, Inc., NJ, USA (2005).
  • Aman MG. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Semin. Pediatr. Neurol. 11(3), 225–228 (2004).
  • Arnold LE, Vitiello B, McDougle C et al. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J. Am. Acad. Child Adolesc. Psychiatry 42(12), 1443–1450 (2003).
  • Militerni R, Bravaccio C, Falco C, Fico C, Palermo MT. Repetitive behaviors in autistic disorder. Eur. Child Adolesc. Psychiatry 11(5), 210–218 (2002).
  • Couturier JL, Speechley KN, Steele M, Norman R, Stringer B, Nicolson R. Parental perception of sleep problems in children of normal intelligence with pervasive developmental disorders: prevalence, severity, and pattern. J. Am. Acad. Child Adolesc. Psychiatry 44(8), 815–822 (2005).
  • Polimeni MA, Richdale AL, Francis AJ. A survey of sleep problems in autism, Asperger’s disorder and typically developing children. J. Intellect. Disabil. Res. 49(Pt 4), 260–268 (2005).
  • Limoges E, Mottron L, Bolduc C, Berthiaume C, Godbout R. Atypical sleep architecture and the autism phenotype. Brain 128(Pt 5), 1049–1061 (2005).
  • Oyane NM, Bjorvatn B. Sleep disturbances in adolescents and young adults with autism and Asperger syndrome. Autism 9(1), 83–94 (2005).
  • Allik H, Larsson JO, Smedje H. Health-related quality of life in parents of school-age children with Asperger syndrome or high-functioning autism. Health Qual. Life Outcomes 4, 1 (2006).
  • Mugno D, Ruta L, D’Arrigo VG, Mazzone L. Impairment of quality of life in parents of children and adolescents with pervasive developmental disorder. Health Qual. Life Outcomes 5, 22 (2007).
  • Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. The incidence of autism in Olmsted County, Minnesota, 1976–1997: results from a population-based study. Arch. Pediatr. Adolesc. Med. 159(1), 37–44 (2005).
  • Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment. Retard. Dev. Disabil. Res. Rev. 8(3), 151–161 (2002).
  • Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. Int. Rev. Psychiatry 15(1–2), 158–165 (2003).
  • Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 289(1), 49–55 (2003).
  • Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108(5), 1155–1161 (2001).
  • Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics 115(3), e277–e282 (2005).
  • Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators. Prevalence of autism spectrum disorders. MMWR Surveill. Summ. 56, 12–28 (2009).
  • Kim YS, Leventhal BL, Koh YJ et al. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 168(9), 904–912 (2011).
  • Barbaresi WJ, Katusic SK, Voigt RG. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch. Pediatr. Adolesc. Med. 160(11), 1167–1175 (2006).
  • Rutter ML. Progress in understanding autism: 2007-2010. J. Autism Dev. Disord. 41(4), 395–404 (2011).
  • Canitano R, Scandurra V. Psychopharmacology in autism: an update. Prog. Neuropsychopharmacol. Biol. Psychiatry 35(1), 18–28 (2011).
  • Warren Z, Veenstra-VanderWeele J, Stone W et al. Therapies for Children with Autism Spectrum Disorders. Comparative Effectiveness Review No. 26. Agency for Healthcare Research and Quality. Report No. AHRQ Publication No. 11-EHC029-EF. Agency for Healthcare Research and Quality, Rockville, MD, USA (2011).
  • Dawson G, Rogers S, Munson J et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 125(1), e17–e23 (2010).
  • Chasson G, Harris G, Neely W. Cost comparison of early intensive behavioral intervention and special education for children with autism. J. Child Fam. Studies 16, 401–413 (2007).
  • Tilford JM. Cost–effectiveness analysis and emergency medical services for children: issues and applications. Ambul. Pediatr. 2(4 Suppl.), 330–336 (2002).
  • Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 12(8), 697–702 (2003).
  • Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost–utility and cost–benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics 25(9), 713–726 (2007).
  • Basu A, Meltzer D. Implications of spillover effects within the family for medical cost–effectiveness analysis. J. Health Econ. 24(4), 751–773 (2005).
  • Bevans KB, Riley AW, Moon J, Forrest CB. Conceptual and methodological advances in child-reported outcomes measurement. Expert Rev. Pharmacoecon. Outcomes Res. 10(4), 385–396 (2010).
  • Baron-Cohen S. Theory of mind in normal development and autism. Prisme 34, 174–183 (2001).
  • Shipman DL, Sheldrick RC, Perrin EC. Quality of life in adolescents with autism spectrum disorders: reliability and validity of self-reports. J. Dev. Behav. Pediatr. 32(2), 85–89 (2011).
  • Sheldrick RC, Neger EN, Shipman D, Perrin EC. Quality of life of adolescents with autism spectrum disorders: concordance among adolescents’ self-reports, parents’ reports, and parents’ proxy reports. Qual. Life Res. 21(1), 53–57 (2012).
  • Rutter M, LeCouteur A, Lord C. ADI-R: The Autism Diagnostic Interview – Revised. Western Psychological Services, CA, USA (2003).
  • Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24(5), 659–685 (1994).
  • Tadevosyan-Leyfer O, Dowd M, Mankoski R et al. A principal components analysis of the Autism Diagnostic Interview – Revised. J. Am. Acad. Child Adolesc. Psychiatry 42(7), 864–872 (2003).
  • Lord C, Risi S, Lambrecht L et al. The Autism Diagnostic Observation Schedule – Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 30(3), 205–223 (2000).
  • Green J, Charman T, McConachie H et al.; PACT Consortium. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial. Lancet 375(9732), 2152–2160 (2010).
  • Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J. Autism Dev. Disord. 39(5), 693–705 (2009).
  • Lord C, Rutter M, Goode S et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J. Autism Dev. Disord. 19(2), 185–212 (1989).
  • Gotham K, Risi S, Pickles A, Lord C. The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J. Autism Dev. Disord. 37(4), 613–627 (2007).
  • Schopler E, van Bourgondien ME, Wellman GJ, Love SR. Childhood Autism Rating Scale (CARS2) (2nd Edition). Western Psychological Services, CA, USA (2010).
  • Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am. J. Ment. Defic. 89(5), 485–491 (1985).
  • Achenbach TM, Rescorla LA. Manual for ASEBA Preschool Forms & Profiles. University of Vermont, Research Center for Children, Youth, and Families, VT, USA (2000).
  • Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr. Rev. 21(8), 265–271 (2000).
  • Sparrow SS, Cicchetti DV, Balla DA. Vineland-II Adaptive Behavior Scales. AGS Publishing, TX, USA (2005).
  • Carter AS, Volkmar FR, Sparrow SS et al. The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism. J. Autism Dev. Disord. 28(4), 287–302 (1998).
  • Constantino JN. The Social Responsiveness Scale. Western Psychological Services, CA, USA (2002).
  • Constantino JN, Todd RD. Genetic structure of reciprocal social behavior. Am. J. Psychiatry 157(12), 2043–2045 (2000).
  • Constantino JN, Davis SA, Todd RD et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the Autism Diagnostic Interview – Revised. J. Autism Dev. Disord. 33(4), 427–433 (2003).
  • Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J. Autism Dev. Disord. 30(3), 237–243 (2000).
  • Gabriels RL, Cuccaro ML, Hill DE, Ivers BJ, Goldson E. Repetitive behaviors in autism: relationships with associated clinical features. Res. Dev. Disabil. 26(2), 169–181 (2005).
  • Coplan J. Atypicality, intelligence, and age: a conceptual model of autistic spectrum disorder. Dev. Med. Child Neurol. 45(10), 712–716 (2003).
  • Coplan J, Jawad AF. Modeling clinical outcome of children with autistic spectrum disorders. Pediatrics 116(1), 117–122 (2005).
  • Mayes SD, Calhoun SL. Ability profiles in children with autism: influence of age and IQ. Autism 7(1), 65–80 (2003).
  • Roid G. Standford–Binet Intelligence Scale (5th Edition) (SB5). Nelson Education Ltd., ON, Canada (2003).
  • Mullen EM. Mullen Scales of Ealry Learning. Pearson Education, Inc., TX, USA (1995).
  • Bayley N. Bayley Scales of Infant and Toddler Development (3rd Edition) (Bayley-III). Pearson Education, Inc., TX, USA (2005).
  • Wechsler D. Wechsler Intelligence Scale for Children (4th Edition) (WISC-IV). Pearson Education, Inc., TX, USA (2003).
  • Arnold LE, Aman MG, Cook AM et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J. Am. Acad. Child Adolesc. Psychiatry 45(10), 1196–1205 (2006).
  • McCracken JT, McGough J, Shah B et al.; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 347(5), 314–321 (2002).
  • McDougle CJ, Scahill L, Aman MG et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am. J. Psychiatry 162(6), 1142–1148 (2005).
  • Luby J, Mrakotsky C, Stalets MM et al. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J. Child Adolesc. Psychopharmacol. 16(5), 575–587 (2006).
  • Nagaraj R, Singhi P, Malhi P. Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J. Child Neurol. 21(6), 450–455 (2006).
  • Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J. Autism Dev. Disord. 31(2), 175–181 (2001).
  • Reeve BB, Hays RD, Bjorner JB et al.; PROMIS Cooperative Group. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med. Care 45(5 Suppl. 1), S22–S31 (2007).
  • Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in healthy and patient populations. Med. Care 39(8), 800–812 (2001).
  • West L, Waldrop J, Brunssen S. Pharmacologic treatment for the core deficits and associated symptoms of autism in children. J. Pediatr. Health Care 23(2), 75–89 (2009).
  • Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul. Pediatr. 3(6), 329–341 (2003).
  • Limbers CA, Ripperger-Suhler J, Heffer RW, Varni JW. Patient-reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in pediatric patients with attention-deficit/hyperactivity disorder and comorbid psychiatric disorders: feasibility, reliability, and validity. Value Health 14(4), 521–530 (2011).
  • Ravens-Sieberer U, Auquier P, Erhart M et al.; European KIDSCREEN Group. The KIDSCREEN-27 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Qual. Life Res. 16(8), 1347–1356 (2007).
  • Landgraf JM, Abertz L, Ware JE. The CHQ User’s Manual. The Health Institute, New England Medical Center, MA, USA (1996).
  • Raat H, Botterweck AM, Landgraf JM, Hoogeveen WC, Essink-Bot ML. Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples. J. Epidemiol. Community Health 59(1), 75–82 (2005).
  • Raat H, Landgraf JM, Bonsel GJ, Gemke RJ, Essink-Bot ML. Reliability and validity of the Child Health Questionnaire – Child Form (CHQ-CF87) in a Dutch adolescent population. Qual. Life Res. 11(6), 575–581 (2002).
  • Jones HP, Guildea ZE, Stewart JH, Cartlidge PH. The Health Status Questionnaire: achieving concordance with published disability criteria. Arch. Dis. Child. 86(1), 15–20 (2002).
  • Riley AW, Forrest CB, Starfield B, Green B, Kang M, Ensminger M. Reliability and validity of the adolescent health profile-types. Med. Care 36(8), 1237–1248 (1998).
  • Riley AW, Forrest CB, Rebok GW et al. The Child Report Form of the CHIP-Child Edition: reliability and validity. Med. Care 42(3), 221–231 (2004).
  • Stein RE, Jessop DJ. Functional status II(R). A measure of child health status. Med. Care 28(11), 1041–1055 (1990).
  • Kuhlthau K, Orlich F, Hall TA et al. Health-related quality of life in children with autism spectrum disorders: results from the Autism Treatment Network. J. Autism Dev. Disord. 40(6), 721–729 (2010).
  • Kamp-Becker I, Schröder J, Muehlan H, Remschmidt H, Becker K, Bachmann CJ. Health-related quality of life in children and adolescents with autism spectrum disorder. Z. Kinder. Jugendpsychiatr. Psychother. 39(2), 123–131 (2011).
  • Limbers CA, Heffer RW, Varni JW. Health-related quality of life and cognitive functioning from the perspective of parents of school-aged children with Asperger’s Syndrome utilizing the PedsQL. J. Autism Dev. Disord. 39(11), 1529–1541 (2009).
  • Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost–effectiveness in Health and Medicine. JAMA 276(15), 1253–1258 (1996).
  • Gold MR, Patrick DL, Hadorn DC et al. Identifying and valuing outcomes. In: Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds). Oxford University Press, NY, USA, 82–134 (1996).
  • Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu. Rev. Public Health 21, 587–611 (2000).
  • Grosse SD, Prosser LA, Asakawa K, Feeny D. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Rev. Pharmacoecon. Outcomes Res. 10(3), 293–308 (2010).
  • Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 115(5), e600–e614 (2005).
  • Smith-Olinde L, Grosse SD, Olinde F, Martin PF, Tilford JM. Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3. Qual. Life Res. 17(6), 943–953 (2008).
  • Nixon Speechley K, Maunsell E, Desmeules M et al. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer. Int. J. Cancer Suppl. 12, 95–105 (1999).
  • Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual. Life Outcomes 1, 54 (2003).
  • Willems DC, Joore MA, Nieman FH, Severens JL, Wouters EF, Hendriks JJ. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders. Int. J. Technol. Assess. Health Care 25(3), 391–399 (2009).
  • Hawthorne G. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument. Value Health 12(6), 948–957 (2009).
  • Ungar W. Economic Evaluation in Child Health. Oxford University Press, NY, USA (2009).
  • Wille N, Badia X, Bonsel G et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual. Life Res. 19(6), 875–886 (2010).
  • Stevens K. Valuation of the Child Health Utility Index 9D (CHU9D). University of Sheffield, Sheffield, UK (2010).
  • Seiber WJ, Groessl EJ, Ganiats TG, Kaplan RM. Quality of Well Being Self-Administered (QWB-SA) Scale: User’s Manual. Health Services Research Center, University of California, CA, USA (2008).
  • Moodie M, Richardson J, Rankin B, Iezzi A, Sinha K. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the Assessment of Quality-of-Life (AQoL-6D) instrument. Value Health 13(8), 1014–1027 (2010).
  • Ravens-Sieberer U, Wille N, Badia X et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual. Life Res. 19(6), 887–897 (2010).
  • Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual. Life Res. 18(8), 1105–1113 (2009).
  • Petrou S, Kupek E. Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland. Med. Decis. Making 29(3), 291–303 (2009).
  • Petrou S, Johnson S, Wolke D, Hollis C, Kochhar P, Marlow N. Economic costs and preference-based health-related quality of life outcomes associated with childhood psychiatric disorders. Br. J. Psychiatry 197(5), 395–404 (2010).
  • Tilford JM, Payakachat N, Kovacs EA et al. Preference-based health-related quality of life outcomes in children with autism spectrum disorders: a comparison of generic instruments. Pharmacoeconomics (2012) (In Press).
  • Brouwer WB, van Exel NJ, Koopmanschap MA, Rutten FF. The valuation of informal care in economic appraisal. A consideration of individual choice and societal costs of time. Int. J. Technol. Assess. Health Care 15(1), 147–160 (1999).
  • Basu A, Dale W, Elstein A, Meltzer D. A time tradeoff method for eliciting partner’s quality of life due to patient’s health states in prostate cancer. Med. Decis. Making 30(3), 355–365 (2010).
  • Brouwer WB, van Exel NJ, Tilford JM. Incorporating caregiver and family effects in economic evaluations of child health. In: Economic Evaluation in Child Health. Ungar WJ (Ed.). Oxford Publisher Press, NY, USA, 55–76 (2009).
  • Schulz R, Beach SR, Lind B et al. Involvement in caregiving and adjustment to death of a spouse: findings from the caregiver health effects study. JAMA 285(24), 3123–3129 (2001).
  • Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S. Long-term care placement of dementia patients and caregiver health and well-being. JAMA 292(8), 961–967 (2004).
  • Bobinac A, van Exel NJ, Rutten FF, Brouwer WB. Health effects in significant others: separating family and care-giving effects. Med. Decis. Making 31(2), 292–298 (2011).
  • Bobinac A, van Exel NJ, Rutten FF, Brouwer WB. Caring for and caring about: disentangling the caregiver effect and the family effect. J. Health Econ. 29(4), 549–556 (2010).
  • Payakachat N, Tilford JM, Brouwer WB, van Exel NJ, Grosse SD. Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual. Life Res. 20(9), 1487–1495 (2011).
  • Brouwer WB, van Exel NJ, van Gorp B, Redekop WK. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual. Life Res. 15(6), 1005–1021 (2006).
  • Prosser LA, Ray GT, O’Brien M, Kleinman K, Santoli J, Lieu TA. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 113(2), 283–290 (2004).
  • Prosser LA, Bridges CB, Uyeki TM et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual. Life Outcomes 3, 18 (2005).
  • Kuhlthau KA, Payakachat N, Delahaye J, Pyne JM, Kovacs E, Tilford JM. Measuring quality of life for caregivers of children with autism spectrum disorder for use in cost–effectiveness evaluations: a mixed method approach. Presented at: The International Society for Quality of Life Research 18th Annual Conference. Denver, CO, USA, 26–29 October 2011.
  • Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J. Consult. Clin. Psychol. 55(1), 3–9 (1987).
  • Dawson G. Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev. Psychopathol. 20(3), 775–803 (2008).
  • Basu A, Heckman JJ, Navarro-Lozano S, Urzua S. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. Health Econ. 16(11), 1133–1157 (2007).
  • Rosenbaum PR, Rubin DB. The central role of the Propensity Score in observational studies for causal effects. Biometrika 70, 41–55 (1983).
  • Basu A. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care. J. Health Econ. 30(3), 549–559 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.